Nanotechnology and the Products of Inherited Regulation
Bibliographic Data
| ID | 11449654 |
|---|---|
| Authors | Elen Stokes (University of Wales, corresponding author) |
| Year | 2012 |
| Volume | 39 |
| Issue | 1 |
| Pages | 93-112 |
| Publication date | 2012-03-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Law and Society (JOURNAL) |
| Journal identifiers | ISSN: 0263-323X • E-ISSN: 1467-6478 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1111/j.1467-6478.2012.00572.x |
| OpenAlex | W2047788690 |
| Language | EN |
| Citations received | 14 |
New technologies do not always elicit new regulatory responses. More often than not, policymakers deal with new technologies by deferring to existing regulatory regimes. This article argues that there are often overlooked consequences of grafting a new technological area, displaying different types of risks and uncertainties, onto an existing regulatory framework. Not only can it entail the application of ill‐suited rules and standards, but it can also involve the reproduction of deeply ingrained traditions and assumptions which, under the weight of history, makes scrutiny extremely difficult. As is shown here, nanotechnology‐enhanced products inherit a raft of consumer protection rules as well as a regulatory predisposition to internal market facilitation. So entrenched is the focus on market opening that making ad hoc changes to existing regulations to incorporate the broader concerns around nano‐products cannot escape the reach of a very powerful market context
Biology · Business · Context (archaeology · Emerging technologies · Industrial organization · Nanotechnology · Political science · Risk analysis (engineering · Scrutiny · Corporate Law and Human Rights · International Environmental Law and Policies · Law · World Trade Organization Law
New Technologies and the Law in War and Peace
Nanotechnology and Risk Governance in the European Union
Regulating Emerging and Future Technologies in the Present
The politics of valuation and payment for regenerative medicine products in the UK
The Abortion Act (1967)
Stretching and Challenging the Boundaries of Law
Steering biomedicine
Cosmopolitics of a Regulatory Fit
Special Treatment? Flexibilities in the Politics of Regenerative Medicine’s Gatekeeping Regimes in the UK
It’s (Not) Just Semantics
L’éclipse
Mind the gap
Legal Repair
Caught in quicksand? Compliance and legitimacy challenges in using regulatory sandboxes to manage emerging technologies
| Citations per year | 1 |
|---|---|
| Citation span | 2012 - 2026 (15) |
| Highly cited | No |